Financial Performance - The Group achieved a consolidated pro-forma turnover of RON 1.57 billion in H1 2025, a 20.3% increase compared to H1 2024 [19] - Pro-forma EBITDA increased by 21.2% to RON 234.2 million, with a margin of 16.1% [34] - IFRS Revenues recorded a solid 20% increase, with 16.2% driven by organic growth [50] - Net cash from operating activities declined by 41% compared to the same period last year [60] Acquisitions and Investments - The Group finalized the acquisition of Routine Med Group in Tulcea in February [21] - A majority stake in All Clinic in the Republic of Moldova was acquired in March [21] - The acquisition of Medstar Clinic Group in Cluj-Napoca was announced in June, with 2024 revenues of approximately RON 32 million [22] - The company launched the first AI assistant integrated into its mobile app [25] - The company enhanced its diagnostic infrastructure with the 2nd automated laboratory line in the Group, with an investment of over EUR 2 million [26] - The company acquired the Illumina sequencing technology with an initial investment of EUR 3 million [27] Operational KPIs - Hospitals revenue increased by 37.8% to RON 437.787 million [50] - Clinics revenue increased by 20.3% to RON 586.623 million [50] - Laboratories revenue increased by 18.4% to RON 172.790 million [50]

25 August 2025 | 1:27AM HKT Centre Testing Intl Group (300012.SZ): 2Q25 inline with accelerating M&A and overseas expansion; Maintain Buy n Life science (which includes food and environment sub-segments): Revenue 1H25 +1% yoy/-3% yoy in 2Q25, normalizing from a high 1H24 base driven by the non-recurring 3rd National Soil Census. Soil-census revenue fell sharply in 1H25 (c.Rmb20mn vs Rmb230–250mn in 1H24), but underlying food and environment (excluding soil-census) continued to grow excluding this impact. Wi ...